GlassScriptPhysician profile
Michael G Tecce
NPI 1851742894
$5,917.67
in general payments reported to CMS, 2019-2025
22 companies · $981 in 2025
The $981 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $129 · 2021: $207 · 2022: $665 · 2023: $375 · 2024: $3,379 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Consulting Fee: $1,475 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.76 |
| Consulting Fee | $1,475.00 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,527.37 | 2024 | Surgimend, Codman Certas, Integra |
| Rti Surgical, INC | $1,396.02 | 2024-2025 | |
| Tela Bio, INC. | $881.19 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $413.23 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $403.70 | 2023-2025 | Alloderm |
| Sientra, INC. | $287.40 | 2019-2022 | |
| Stryker Corporation | $173.49 | 2025 | Spy-Phi System |
| Medical Device Business Services, INC. | $155.60 | 2020-2022 | |
| Allergan, INC. | $133.04 | 2022 | |
| Kerecis Limited | $106.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $82.79 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $70.91 | 2024 | Exparel |
| Coopersurgical, INC. | $49.28 | 2025 | Onetrac Lx |
| Solventum Corporation | $33.74 | 2025 | Prevena |
| Depuy Synthes Sales INC. | $33.73 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.06 | 2025 | Tisseel |
| Medtronic, INC. | $29.60 | 2025 | Transorb |
| Davol INC. | $29.19 | 2025 | Phasix Mesh |
| Motiva USA, LLC | $24.03 | 2025 | |
| Merck Sharp & Dohme LLC | $23.25 | 2024 | Keytruda, Lynparza |
| Smith+Nephew, INC. | $21.48 | 2024 | Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tecce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.